Monday, April 6, 2020

Urgently Responding to This Outbreak, Vigilantly Preparing for the Next

With the outbreak of COVID-19, the WuXi AppTec community is committed to helping the world pivot from fear to determination and effective action. On February 25, in an effort...

Collaborating Against COVID-19

WuXi AppTec is convening with experts, from our company and around the world, for ongoing analysis of the COVID-19 pandemic and partnering with other industry leaders on actions to...

Harvard’s Francisco Quintana Explores the Impact of Environmental Factors on the Pathogenesis of Multiple...

Multiple sclerosis, an autoimmune disorder, is one of the more prevalent rare diseases worldwide. An estimated 2.3 million people are living with multiple sclerosis, whose cause remains unknown. Francisco J....

LET SCIENCE LEAD: A Special Online Forum on COVID-19

“The only way we will defeat this outbreak is for all countries to work together in a spirit of solidarity and cooperation. We are all in this together, and we can...

Apitope’s Research Seeks to Put Cause of Multiple Sclerosis into Remission

The National Organization of Rare Diseases (NORD) describes multiple sclerosis (MS) as a chronic neuroimmunologic disorder involving the brain, spinal cord and optic nerves. MS is just one of...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Reports Strong 2019 Annual Results

WuXi AppTec Reports Strong 2019 Annual Results Revenue Growth Accelerated 33.9% Year-Over-Year to RMB12,872 Million Adjusted...